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EFFECT  OF  COLCHICINE  ON  THE  ANTIBODY  RESPONSE 
II.  Demonstration of the Inactivation of Suppressor Cell Activities by 
Colchicine* 
BY  PANG  N.  SHEK,$  CARL WALTENBAUGH,§ AND ALBERT H.  COONSt] 
(From the Department of Pathology,  Harvard Medical School, Boston, Massachusetts 02115) 
Experiments reported in the preceding paper established the experimental conditions 
for the optimal enhancement of the antibody formation by colchicine (CC) 1 in mice (1). 
The effectiveness of CC  in  potentiating the  antibody response  raises  the  tantalizing 
question of how the drug acts to cause the enhancement. Since suppressor cells play an 
important role in the regulation of the antibody response  (2-5),  and the generation of 
these predominantly radiation-sensitive regulatory cells apparently requires mitosis (4, 
6, 7), it is reasonable to assume that any interference with their proliferation or that of 
their precursors would reduce negative regulation.  Considering the dose range (1.0-1.5 
mg/kg) of CC which we find to be effective in enhancing antibody formation (1), one 
which has been shown to be anti-mitotic (8,  9),  it is likely that CC exerts its mitosis- 
blocking effect on early dividing suppressor cells soon aider their encounter with antigen 
(3,  7,  10,  11). Suppressor cells are thymus-derived (T) lymphocytes which suppress the 
antibody response in a number of systems (12-15). Thus it seems likely that in a system 
where T-cell  regulation is absent,  CC should be ineffective in enhancing the antibody 
response. 
The random synthetic copolymer of L-glutamic acidS°-L-tyrosine  5° (GT),  which is not 
immunogenic  in  any  of more  than  20  inbred  strains  of mice,  stimulates  antibody 
responses when coupled to the immunogenic carrier, methylated bovine serum albumin 
(GT-MBSA)  (16). Preimmunization with GT suppresses the plaque-forming cell  (PFC) 
response to GT-MBSA in BALB/c mice.  The specific suppressor activity has been shown 
to be mediated by T cells (17) and to be sensitive to cyclophosphamide (18). Therefore, in 
a system where specific suppressor T cells can be demonstrated, CC should be capable of 
preventing their activity. 
Results  obtained  in  the  present  study demonstrate that  in  the  antibody 
response to a  T-independent antigen, e.g.  2,4,6-trinitrophenyl-keyhole limpet 
hemocyanin  (TNP-KLH)-Sepharose  (19),  CC  effectively  induces  an  elevated 
hapten-specific PFC response in intact animals, but not in congenitally athymic 
nude  mice where T-cell regulation  is  absent.  Furthermore,  the generation  of 
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GT-induced suppressor cells  and the transfer  of their  suppressive activity  to 
normal syngeneic recipients  can be effectively  prevented by the administration 
of  CC. 
Materials and Methods 
Animals.  BALB/c mice were purchased from the same suppliers and maintained  under the 
conditions described in the preceding paper (1). 
Antigens and Immunization.  The TNP-KLH used in this study was the same as that described 
previously (1). The hapten-carrier was conjugated to Sepharose 2-B (Pharmacia Fine Chemicals, 
Inc.,  Piscataway,  N.  J.)  using  the  method  described  by  Feldmann  et  al.  (19).  The  synthetic 
random copolymer, GT, with an average tool wt of 133,000, as well as the terpolymer of L-glutamic 
acid~°-L-alanine~°-L-tyrosine  l° (GAT), tool wt 35,000,  were obtained from Miles Laboratories Inc., 
Miles Research  Products,  Elkhart,  Ind.  MBSA was purchased  from  Worthington  Biochemical 
Corp., Freehold, N. J. The GT-MBSA complex was prepared by the dropwise addition of MBSA 
(5 mg/ml) while stirring,  to a  solution of GT (1 mg]ml).  Ai~r a  20-min interval during which 
maximum flocculation and aggregation occurred, the precipitate of GT-MBSA was washed three 
times in saline. For immunization, mice were injected intraperitoneally with 10 #g of GT as GT- 
MBSA in complete Freund's adjuvant (Difco Laboratories, Detroit, Mich.). CC (Sigma Chemical 
Co., St.  Louis, MO.) was freshly dissolved in physiological saline and administered intraperito- 
neally to animals at a dose of 1 mg/kg body weight. 
Cell Transfers.  BALB/c mice used as cell donors were injected intraperitoneally with Maalox, 
100  #g  GT in  Maalox,  or  100  #g  GT in  Maalox  and  1.0  mg CC/kg.  3  days  later,  mice were 
sacrificed and their spleens were removed. Single cell suspensions were prepared,  washed three 
times in Hanks' balanced salt solution, and 20  ×  l0  s lymphoid cells were adoptively transferred 
intravenously  into  normal  syngeneic  recipients.  Mice  were  then  immunized  with  GT-MBSA 
immediately after transfer. 
Hemolytic Plaque Assay.  The TNP-specific PFC response of immune animals was assessed as 
described  previously  (1). The  PFC  response  to  GT-MBSA was  assayed  on  sheep  erythrocytes 
(SRBC) coupled with the cress-reacting polymer GAT, GAT-SRBC (20). GT-specific plaques were 
determined by subtracting the number of PFC remaining after inhibition by a suitable dilution of 
GAT from the number of plaques detected on GAT-SRBC in the absence of the specific inhibitor 
(21). 
Results 
CC Enhances  the PFC Response of Normal and Nude Mice to TNP-KLH- 
Sepharose.  Although TNP-KLH  is  a  thymus-dependent antigen,  Feldmann 
and  his  colleagues have demonstrated that  the conjugation of TNP-KLH  to 
Sepharose  (TKS)  renders  it  thymus-independent (19). We  performed experi- 
ments to test the effectiveness of CC in enhancing the antibody response to TKS 
in intact animals and in nude mice where T-cell regulation is absent. It can be 
seen from Fig.  1 that the simultaneous injection of CC with TKS into normal 
mice enhanced their  hapten-specific PFC  response.  On the  other hand,  the 
administration of CC to congenitally athymic nude mice failed to increase their 
response (Table I). 
CC Abrogates GT-Induced Suppression  of the PFC Response to GT-MBSA. 
It has been established that preinjection of the copolymer GT suppresses the 
GT-specific PFC response of certain inbred mouse strains, e.g. BALB/c mice, to 
a  challenge of the immunogenic GT-MBSA antigen (21). GT-induced suppres- 
sion  results  from  the  stimulation  of specific  suppressor  T  cells  (5,  17). We 
adopted this system to test the effect of CC on the generation of GT-stimulated 
suppressor cells.  First,  we examined the effectiveness of CC  in blocking GT 
from inducing nonresponsiveness to GT-MBSA in BALB/c animals.  It can be 1230  INACTIVATION OF  SUPPRESSOR CELLS BY  COLCHICINE 
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FIo. i.  Kinetics of  the TNP-specific primary IgM PFC response of  BALB/c mice to TKS. 
Animals in  the  control  group (O)  were immunized intraperitoneally  with 100/~g  of  TKS on 
day 0, and animals in the experimental group (0) were similarly  immunized, except that 
CC was also  administered at a dose of  I mg/kg body weight. On each day from day 5 to  day 
8 after  the injection,  spleens of  the injected  animals were assayed for their  TNP-specific 
IgM PFC response.  Each point represents the mean PFC ± SE of  5-10 animals. SC, spleen 
cells. 
TABLE  I 
Effect of CC on the Primary Hapten-Specifw PFC Response to TKS in BALB/c and 
Nude Mice 
Num-  Day 0  Day 7 
Group  Strain  ber of  TNP-specific IgM PFC  P 
mice  Treatment  per spleen 
Mean ± SE 
I  BALB/c  10  TKS*  10,170 + 1,310 
II  BALB/c  10  TKS + CC$  25,980 +- 3,190 
III  Nude  6  TKS  8,500 ± 1,200 
(nu]nu) 
IV  Nude  6  TKS + CC  9,290 +- 1,020 
(nu/nu) 
<0.003§ 
n.s,II 
* 100 ~g of  TKS injected  i.p. 
$ CC administered at 1 mg/kg body weight, i.p. 
§  P value in comparison to group I. 
II  n.s.,  not significant  in comparison to group Ill. 
seen  from Table  II that  prior  injection of GT  effectively suppressed  the  GT- 
specific  PFC  responses  of the  injected  animals  in  group  II to  a  subsequent 
challenge with GT-MBSA. On the other hand, animals in group III, preinjected 
with  GT as  well  as  CC,  developed a  PFC  response to  GT-MBSA no different 
from that of control animals in group I. 
Results of experiments described above strongly imply that CC may abolish 
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TABLE  II 
Effect of CC on GT-Induced Suppression of the PFC Response to GT-MBSA in BALB/c 
Mice 
Day -3  Day 0  Day 7 
Group  Number of  p, 
mice  Treatment  GT-specific PFC 
per spleen 
Mean  +- SE 
I  9  Maalox  GT-MBSA$  4,240  -+ 770 
II  9  GT§  GT-MBSA  160  -  20  <0.001 
III  8  GT +  CC[[  GT-MBSA  4,180  -+ 400  n.s.¶ 
*  P values in comparison to group I. 
$ i0 ~g of  GT as GT-MBSA  in complete Freund's adjuvant, i.p. 
§ 100/~g of  GT in Maalox, i.p. 
[I  CC administered at 1 mg/kg body weight, i.p. 
¶ n.s.,  not significant. 
TABLE  III 
Effect of CC on the Transfer of Suppression of GT-Specific PFC Response to Normal 
Syngeneic Recipients (BALB/c Mice) 
Day -3  Day 0  Day 7 
Sum- 
Group  Donors  Normal sygeneic recipients  GT-specific  ber of  P* 
IgG PFC  mice 
Spleen cells  Immunization  per spleen  Treatment  transferred 
Mean  +_ SE 
I  Maalox  20  ×  106  GT-MBSA*  5,780  _  930  12 
II  GT§  20  x  106  GT-MBSA  500  +_. 160  12  <0.001 
III  GT +  CC[]  20  x  l0  s  GT-MBSA  6,150  _  1,040  12  n.s.¶ 
*  P values in comparison to group I. 
* i0/~g of  GT as GT-MBSA  in complete Freund's adjuvant, i.p. 
§ 100 ~g of  GT in Maalox, i.p. 
[[  CC administered at 1 mg/kg body weight, i.p. 
¶ n.s.,  not significant. 
implication were correct,  one would predict that the administration of CC to 
GT-primed donors should prevent the transfer of suppressor activity to normal 
syngeneic  ~ecipients.  It  can  be  seen from Table  III that the transfer of GT- 
primed spleen cells to normal syngeneic recipients immunized with GT-MBSA 
significantly suppressed the IgG PFC response to GT-MBSA (compare groups II 
and I). In contrast, the injection of CC to cell donors at the time of priming with 
GT abolished the transfer of suppressor activity to normal recipients challenged 
with GT-MBSA (compare groups III and II).  These results suggested that CC 
abolished  GT-specific  suppression  by  the  inactivation  or elimination  of GT- 
stimulated suppressor cells. 
Discussion 
Studies reported in the preceding paper clearly established the effect of CC in 
enhancing the antibody response in mice (1). Results of experiments presented 1232  INACTIVATION  OF  SUPPRESSOR CELLS BY COLCHICINE 
in  this  paper  have  demonstrated  that  (a)  CC  is  ineffective  in  potentiating 
antibody  formation  in  mice  in  which  T-cell  regulation  is absent  and  (b)  CC 
abolishes the expression of GT-induced suppressor cell activities. 
It could be argued that CC induces an elevated antibody response by its direct 
effect on B cells. Hence, we tested its action on congenitally athymic mice to a 
T-independent  antigen,  TKS.  Our  results  indicate  that  CC  did  not enhance 
antibody formation in homozygous nude (nu/nu) mice where T-cell regulation is 
absent (Table I). In contrast, the hapten-specific PFC response of intact animals 
to  TKS  can  be  enhanced  by  CC  (Fig.  1).  Although  it  has  been  shown  by 
Feldmann et al.  (19) that  helper T  cells and macrophages are not required to 
elicit a  hapten-specific response to TKS, the magnitude of the response might 
still  be  under  the  control  of regulatory  T  cells,  e.g.  suppressor  cells.  The 
effectiveness of CC in elevating the antibody response to TKS in intact animals 
where T-cell regulation  is present,  and the failure of the drug to enhance the 
response to the  same T-independent  antigen  in T-cell-deficient mice strongly 
imply that under our experimental conditions, one of the target cells acted upon 
by CC  is  a  regulatory  T  cell.  Our  observation is analogous to the  report by 
Baker et al.  (22, 23) that anti-lymphocyte serum enhanced the response to type 
III pneumococcal polysaccharide,  a  T-independent  antigen,  in  intact  animals 
but not in T-cell-deficient nude animals. 
Although results up to this point suggested that CC acts on suppressor cells, 
direct evidence to support the view was lacking. To demonstrate that CC in fact 
inactivates suppressor cells, we used a well-established system in which specific 
suppressor T cells are induced by the injection of GT in BALB/c animals (5, 21). 
It is clear from these experiments that the simultaneous  injection of CC with 
GT  effectively  prevented  the  induction  of  GT-specific  suppression  of  PFC 
response to GT-MBSA (Table II). Furthermore, the administration of CC to GT- 
primed  donor  animals  abolished  the  cell-mediated  transfer  of  suppressive 
activity to normal syngeneic recipients challenged with GT-MBSA (Table III). 
This  observation  provided direct  evidence that  CC  inactivated  or eliminated 
suppressor  T  cells.  It  is  noteworthy that  GT-specific suppression  in  BALB/c 
mice can also be abolished by pretreatment with cyclophosphamide (18). 
The  selective  action  of CC  on the  inactivation  of suppressor cells or their 
precursors appears to be a matter of the appropriate time of its administration. 
Recent  studies  by  Eardley  and  Sercarz  (10)  demonstrated  that  a  wave  of 
suppression occurs as the initial event immediately following immunization  in 
a hapten-carrier system, and that carrier-specific suppressor cells are generated 
as  early  as  24  h  after  the  injection  of antigen.  Moreover,  such  suppression 
required cell division (7). Hence, the finding that simultaneous administration 
of CC with an antigen consistently enhances the antibody response (1), and that 
CC  is  capable  of inactivating  suppressor  cell  activities  (Tables  II  and  III), 
strongly substantiate  the  view that  CC  interferes with the  generation  of the 
initial wave of suppression, and this in turn leads to a subsequent augmentation 
of the antibody response. 
Of course,  the  demonstration  that  CC  acts  on  suppressor  cells  does  not 
exclude  the  possibility  that  it  may  also  be  acting  on  other  cell  types.  For 
example, we cannot rule out as yet its possible effect on macrophages,  and its 
possible action on helper T cells in the enhancing process. A possible contribu- PANG  N.  SHEK~  CARL  WALTENBAUGH,  AND  ALBERT  H.  COONS  1233 
tion by macrophages in enhancing the antibody response may be partly the 
result of increased efficiency of macrophages in processing the antigen. How- 
ever, CC has been shown to inhibit phagocytosis (24-26)  and to interfere with 
certain metabolic processes in particle ingestion (24, 27). Thus, these observa- 
tions on the effect of CC  upon neutrophil and macrophage functions suggest 
that the administration of CC with an antigen probably would not significantly 
facilitate macrophages in antigen processing. It also appears unlikely to us that 
any interference with the generation of helper T cells by an anti-mitotic dose of 
CC would facilitate rather than impair helper function. In view of our current 
finding that the early administration of CC in relation to antigen injection is a 
prerequisite for successful enhancement of tl/e antibody response,  we tend to 
favor the alternative possibility that suppressor cells or their precursors, which 
appear early after antigenic stimulation, are its principal targets. 
Summary 
The  simultaneous administration of colchicine  (CC)  with a  T-independent 
antigen,  e.g.  2,4,6-trinitrophenyl-keyhole limpet  hemocyanin-Sepharose, to 
intact animals effectively enhanced their hapten-specific plaque-forming cell 
(PFC) response.  However, in congenitally athymic nude mice in which T-cell 
regulation was absent,  CC was ineffective in producing enhancement. These 
observations  suggest  that  the  target  cell  acted  upon  by  CC  is  most  likely 
thymus-derived. Furthermore, the injection of CC  with the co-polymer of L- 
glutamic acidS°-L-tyrosine  5° (GT)  abolished GT-specific suppression of the PFC 
response to GT-methylated bovine serum albumin. Spleen cells from CC-treated 
and GT-primed hosts could no longer transfer suppressive activity to normal 
recipients. These results provide evidence that CC is capable of inactivating or 
eliminating suppressor cells or their precursors.  Thus,  CC-induced enhance- 
ment of the antibody response may be explained, at least in part, by its anti- 
mitotic, and hence lethal effect on dividing suppressor T cells. 
The authors wish  to thank Daniel Cargill and Linda Kapp  for their excellent  technical  assistance. 
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